A Study to Evaluate the Ocular Blood Flow Effects of Unoprostone Isopropyl in Adults With Dry Age-related Macular Degeneration

Trial Profile

A Study to Evaluate the Ocular Blood Flow Effects of Unoprostone Isopropyl in Adults With Dry Age-related Macular Degeneration

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Apr 2014

At a glance

  • Drugs Unoprostone (Primary)
  • Indications Dry age-related macular degeneration
  • Focus Pharmacodynamics
  • Sponsors Sucampo Pharmaceuticals
  • Most Recent Events

    • 12 Apr 2014 New trial record
    • 21 Mar 2013
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top